• Masitinib (AB1010): Technical Use in KIT/PDGFR Inhibition Wo

  2026-07-22

  Masitinib (AB1010) is a selective tyrosine kinase inhibitor optimized for DMSO-based workflows targeting KIT, PDGFRα, and PDGFRβ. It is particularly useful in research on cancer (notably GIST), mastocytosis, and inflammatory diseases where precise kinase inhibition is required. It should not be used in protocols requiring aqueous or ethanol solubility, nor for broad-spectrum kinase inhibition.

• Structure-Based Screening Identifies NSP15 Inhibitors for SA

  2026-07-22

  This study employed a structure-based virtual screening approach to identify potent natural product inhibitors of NSP15, a viral endoribonuclease critical to SARS-CoV-2 immune evasion. The discovery of thymopentin and oleuropein as high-affinity, stable NSP15 inhibitors provides new directions for antiviral research and drug development.

• Cl-Amidine Trifluoroacetate: PAD4 Inhibition and Translation

  2026-07-21

  This thought-leadership article explores the strategic deployment of Cl-Amidine (trifluoroacetate salt) as a selective PAD4 inhibitor in translational research. By dissecting mechanistic insights into PAD4-driven epigenetic and immune processes, it bridges foundational evidence from cancer and inflammatory disease models with actionable guidance for researchers. Drawing on recent discoveries in chronic myeloid leukemia and sepsis, the article maps the competitive landscape, protocol strategies, and outlook for PAD4 inhibition as a pivot point in disease modeling and therapeutic innovation.

• Estrogen Receptor–Autophagy Axis Protects Organs in Perimeno

  2026-07-21

  This study elucidates how estrogen receptor signaling and autophagy collaborate to protect the heart, aorta, and kidneys during perimenopausal aging. By integrating human cohort data, mouse models, and network pharmacology, the research demonstrates that estrogen’s organ-protective effects depend on receptor-mediated autophagy activation, offering new insight for precision hormone therapy.

• Reversine and Aurora Kinase Inhibition: Mechanistic Insights

  2026-07-20

  Explore the molecular mechanisms of Reversine as an Aurora kinase inhibitor, with a unique focus on mitotic checkpoint disassembly and practical assay optimization. This in-depth article offers new perspectives for cancer cell proliferation inhibition and apoptosis induction research.

• APEX2 Regulates TERT Expression via DNA Repeat Elements in h

  2026-07-20

  A new study demonstrates that APEX2, but not APEX1, is essential for efficient TERT gene expression in human embryonic stem cells by acting on repetitive DNA elements like MIRs. These insights expand our understanding of telomerase regulation and have implications for stem cell biology and cancer research.

• Meropenem: β-Lactam Antibiotic Carbapenem in Resistance Work

  2026-07-19

  Meropenem’s ultra-broad spectrum and reliable activity against Gram-negative and Gram-positive bacteria make it a gold standard for resistance modeling in the lab. This article unpacks stepwise protocols, troubleshooting insights, and cutting-edge innovations—anchored by recent transmission studies—to help researchers maximize reproducibility in septicemia and carbapenem-resistance research.

• AMPK Activation by L. plantarum P101 Mitigates Alcoholic Ste

  2026-07-18

  This study demonstrates that Lactiplantibacillus plantarum P101 alleviates alcohol-induced hepatic lipid accumulation in mice primarily via activation of the AMPK signaling pathway. Using targeted inhibition and integrative gut microbiota-metabolomics analysis, the research establishes mechanistic links between probiotic intervention, metabolic regulation, and hepatic outcomes.

• ATP Solution Empowers Kinase and mRNA Workflows in Oncology

  2026-07-17

  ATP Solution (100 mM) from APExBIO delivers unmatched purity and stability for sensitive kinase, in vitro transcription, and phosphorylation assays. Leveraging new insights from tumor suppressor mRNA delivery, this guide translates bench breakthroughs into optimized experimental protocols and troubleshooting strategies.

• Halazone: Applied Workflows for Antimicrobial and Neurophysi

  2026-07-17

  Halazone uniquely bridges rapid water disinfection with sodium channel modulation, empowering researchers to tackle both microbial safety and neurophysiological questions within a single workflow. This guide details protocol enhancements, troubleshooting, and advanced applications, leveraging APExBIO’s Halazone for robust experimental outcomes.

• Live-Dead Bacterial Staining Kit: Precision in Nanomaterial

  2026-07-16

  Discover how the Live-Dead Bacterial Staining Kit enables rigorous bacterial viability assessment in advanced nanomaterial antibiosis research. Explore unique protocol insights, membrane disruption mechanisms, and decision-critical innovations that set this microbiology research staining kit apart.

• Genotyping Kit for Target Alleles: Precision in Host-Microbe

  2026-07-16

  Explore how the Genotyping Kit for target alleles of insects, tissues, fishes and cells accelerates PCR-based research with single-tube DNA extraction and robust amplification. This article uniquely connects genotyping workflows to emerging insights in host-microbe interaction studies, offering practical protocol parameters and advanced applications.

• SINAT Proteins Regulate Autophagic Vesicle Degradation in Ar

  2026-07-15

  This study reveals how Arabidopsis SINAT proteins modulate autophagic vesicle degradation by targeting the V-ATPase subunit VAB1 for ubiquitination and proteolysis. The findings clarify a critical link between ubiquitin-mediated regulation and vacuolar acidification, advancing understanding of plant autophagy and cellular pH homeostasis.

• EPZ5676 (A4166): Precision DOT1L Inhibition for Leukemia Res

  2026-07-15

  This article provides a scenario-driven, evidence-based guide for bench scientists evaluating EPZ5676 (SKU A4166) as a potent and selective DOT1L inhibitor in cell viability, proliferation, and cytotoxicity assays. Emphasizing data-backed workflow optimization and vendor reliability, it demonstrates how APExBIO's EPZ5676 sets new standards in epigenetic modulation research.

• ALDOB K87 Lactylation Drives Mitochondrial Remodeling in PH

  2026-07-14

  Yi et al. reveal that lysine-87 lactylation of aldolase B (ALDOB) orchestrates mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). By establishing the lactate–ALDOB–DRP1 signaling axis, this study provides a mechanistic framework connecting metabolic shifts to pathological smooth muscle cell proliferation, opening new avenues for targeted intervention.

16299 records 1/1087 page Next 12345 下5页 Last page